Rafael Holdings, Inc.(RFL)
1.15-0.02-1.71%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Rafael Holdings, Inc.所属市场NYSE成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Rafael Holdings, Inc.是一家生物技术公司，在特拉华州注册成立，专注于开发药品，并持有临床和早期生物技术及医疗器械公司的战略权益。该公司的主要候选临床药物是Trappsol Cyclo，这是一种正在关键的3期临床试验中进行评估的疗法，用于治疗Niemann-Pick病C1型（NPC1），这是一种罕见且致命的遗传性疾病，会破坏胆固醇代谢。- 12-12Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 12-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 12-11Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities交易所摘牌声明Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 12-02Form 8-K - Current report重要事件披露Form 8-K - Current report
- 10-29Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 10-29Form 8-K - Current report重要事件披露Form 8-K - Current report
- 10-28Form 8-K - Current report重要事件披露Form 8-K - Current report
- 10-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 08-08Form 8-K - Current report重要事件披露Form 8-K - Current report
- 07-18Form 8-K - Current report重要事件披露Form 8-K - Current report
- 06-26Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 06-18Form 8-K - Current report重要事件披露Form 8-K - Current report
- 06-11Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 06-11Form 8-K - Current report重要事件披露Form 8-K - Current report
- 06-04Form 8-K - Current report重要事件披露Form 8-K - Current report
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
1.19
今开
1.18
量比
5.25
最低
1.15
昨收
1.17
换手率
0.20%